Sabin-related poliovirus vaccine strains isolated from transverse myelitis cases in Brazil
| Published in: | Revista do Instituto de Medicina Tropical de São Paulo |
|---|---|
| Main Authors: | F. Friedrich, A. M. B. Filippis, H. G. Schatzmayr |
| Format: | Article |
| Language: | English |
| Published: |
Universidade de São Paulo (USP)
1995-12-01
|
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46651995000600013 |
Similar Items
Temporal association between the isolation of Sabin-related poliovirus vaccine strains and the Guillain-Barré syndrome
by: F. Friedrich, et al.
Published: (1996-02-01)
by: F. Friedrich, et al.
Published: (1996-02-01)
A phase 2 study of a combined diphtheria-tetanus-acellular pertussis vaccine with a Sabin-derived inactivated poliovirus vaccine in children
by: Takashi Nakano, et al.
Published: (2018-12-01)
by: Takashi Nakano, et al.
Published: (2018-12-01)
Potency of the Sabin inactivated poliovirus vaccine (sIPV) after exposure to freezing temperatures in cold chains
by: Wei Cai, et al.
Published: (2020-08-01)
by: Wei Cai, et al.
Published: (2020-08-01)
Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine
by: Chiemi Hotta, et al.
Published: (2019-05-01)
by: Chiemi Hotta, et al.
Published: (2019-05-01)
Effect of maternal antibody on the infant immune response to inactivated poliovirus vaccines made from Sabin strains
by: Rong Tang, et al.
Published: (2019-05-01)
by: Rong Tang, et al.
Published: (2019-05-01)
Rare adverse events associated with oral poliovirus vaccine in Brazil
by: Friedrich F.
Published: (1997-01-01)
by: Friedrich F.
Published: (1997-01-01)
MMR Vaccine and Transverse Myelitis
by: J Gordon Millichap
Published: (1995-09-01)
by: J Gordon Millichap
Published: (1995-09-01)
Safety and immunogenicity of a new Sabin inactivated poliovirus vaccine candidate produced on the PER.C6® cell-line: a phase 1 randomized controlled trial in adults
by: Isabel Leroux-Roels, et al.
Published: (2021-05-01)
by: Isabel Leroux-Roels, et al.
Published: (2021-05-01)
Safety, Immunogenicity and Lot-to-Lot Consistency of Sabin-Strain Inactivated Poliovirus Vaccine in 2-Month-Old Infants: A Double-Blind, Randomized Phase III Trial
by: Yan Zheng, et al.
Published: (2022-02-01)
by: Yan Zheng, et al.
Published: (2022-02-01)
Immunogenicity and Safety of Inactivated Sabin-Strain Polio Vaccine “PoliovacSin”: Clinical Trials Phase I and II
by: Anastasia Piniaeva, et al.
Published: (2021-05-01)
by: Anastasia Piniaeva, et al.
Published: (2021-05-01)
Quantitative Analysis of the Instant and Persistent Inhibition Effects of Maternal Poliovirus Antibodies on the Immune Response in a Phase IV Trial of a Sabin Strain-Based Inactivated Poliovirus Vaccine
by: Qiongzhou Yin, et al.
Published: (2024-02-01)
by: Qiongzhou Yin, et al.
Published: (2024-02-01)
Acute Transverse Myelitis after COVID-19 Vaccination
by: Yu-Ting Hsiao, et al.
Published: (2021-09-01)
by: Yu-Ting Hsiao, et al.
Published: (2021-09-01)
Vaccine Induced Acute Transverse Myelitis: A Case Report
by: Avinash Chandra, et al.
Published: (2016-12-01)
by: Avinash Chandra, et al.
Published: (2016-12-01)
Generation of Polyclonal Antibodies Against Sabin Poliovirus D- and H-Antigens and Their Application in ELISA
by: Anna Zyrina, et al.
Published: (2025-09-01)
by: Anna Zyrina, et al.
Published: (2025-09-01)
Case Report: The Rehabilitation of a Patient with Acute Transverse Myelitis after COVID-19 Vaccination
by: Piotr Niebrzydowski, et al.
Published: (2024-06-01)
by: Piotr Niebrzydowski, et al.
Published: (2024-06-01)
A phase Ⅱ, randomized, controlled trial to evaluate the safety and immunogenicity of a Sabin strain-based inactivated polio vaccine
by: Rong Tang, et al.
Published: (2020-11-01)
by: Rong Tang, et al.
Published: (2020-11-01)
Safety and immunogenicity of 3 formulations of a Sabin inactivated poliovirus vaccine produced on the PER.C6® cell line: A phase 2, double-blind, randomized, controlled study in infants vaccinated at 6, 10 and 14 weeks of age
by: Anna Lisa Ong-Lim, et al.
Published: (2022-11-01)
by: Anna Lisa Ong-Lim, et al.
Published: (2022-11-01)
Immune persistence of an inactivated poliovirus vaccine derived from the Sabin strain: a 10-year follow-up of a phase 3 studyResearch in context
by: Lei Ma, et al.
Published: (2023-10-01)
by: Lei Ma, et al.
Published: (2023-10-01)
Pediatric Acute Longitudinal Extensive Transverse Myelitis Secondary to Neuroborreliosis
by: Sana Khan, et al.
Published: (2015-07-01)
by: Sana Khan, et al.
Published: (2015-07-01)
Immune Persistence following Primary Immunization and the Immunogenicity and Safety of a Booster Dose of a Multidose Sabin Strain-Based Inactivated Polio Vaccine in Infants Aged 18 Months
by: Guangwei Feng, et al.
Published: (2024-01-01)
by: Guangwei Feng, et al.
Published: (2024-01-01)
Sabin polio virus protein 1 (VP1) evolution in patients with acute flaccid paralysis from 2010 to 2016 in Uganda
by: Mary Bridget Nanteza, et al.
Published: (2023-08-01)
by: Mary Bridget Nanteza, et al.
Published: (2023-08-01)
Subacute transverse myelitis with Lyme profile dissociation
by: Ajjan, Mohammed, et al.
Published: (2008-06-01)
by: Ajjan, Mohammed, et al.
Published: (2008-06-01)
Clinical and Radiological Longitudinal 3-month Prospective Follow-up of Patients with Dengue-associated Longitudinally Extensive Transverse Myelitis
by: Haramohan Sahoo, et al.
Published: (2025-01-01)
by: Haramohan Sahoo, et al.
Published: (2025-01-01)
Clinical characteristics and predictive factors of recurrent idiopathic transverse myelitis
by: Eun Kyoung Lee, et al.
Published: (2024-09-01)
by: Eun Kyoung Lee, et al.
Published: (2024-09-01)
Cervical Transverse Myelitis After Chickenpox in An Immunocompetent Patient
by: Mehrnaz Rasoolinejad, et al.
Published: (2010-11-01)
by: Mehrnaz Rasoolinejad, et al.
Published: (2010-11-01)
Prognosis of Acute Transverse Myelitis
by: J Gordon Millichap, et al.
Published: (2014-01-01)
by: J Gordon Millichap, et al.
Published: (2014-01-01)
Longitudinally extensive transverse myelitis as an initial manifestation of sarcoidosis: A rare case and its management
by: Aman Kumar, et al.
Published: (2024-07-01)
by: Aman Kumar, et al.
Published: (2024-07-01)
Immunogenicity of two-dose and three-dose vaccination schedules with Sabin inactivated poliovirus vaccine in China: An open-label, randomized, controlled trial
by: Yamin Wang, et al.
Published: (2021-05-01)
by: Yamin Wang, et al.
Published: (2021-05-01)
Case of Poliomyelitis Caused by Significantly Diverged Derivative of the Poliovirus Type 3 Vaccine Sabin Strain Circulating in the Orphanage
by: Ekaterina A. Korotkova, et al.
Published: (2020-09-01)
by: Ekaterina A. Korotkova, et al.
Published: (2020-09-01)
Transverse myelitis after COVID-19 disease: a case report
by: I. Vienažindytė, et al.
Published: (2023-10-01)
by: I. Vienažindytė, et al.
Published: (2023-10-01)
Sarcoidosis Presenting as Longitudinally Extensive Transverse Myelitis: A Case Report
by: Joudia Touri, et al.
Published: (2024-06-01)
by: Joudia Touri, et al.
Published: (2024-06-01)
Transverse myelitis after COVID-19 disease: a case report
by: I. Vienažindytė, et al.
Published: (2023-10-01)
by: I. Vienažindytė, et al.
Published: (2023-10-01)
Safety, immunogenicity, and lot-to-lot consistency of a multidose Sabin strain-based inactivated polio vaccine: a phase III, randomized, blinded, positive-control clinical trial in infants aged 2 months
by: Guangwei Feng, et al.
Published: (2023-05-01)
by: Guangwei Feng, et al.
Published: (2023-05-01)
Acute transverse myelitis (ATM) associated with COVID 19 infection and vaccination: A case report and literature review
by: Srinivas Medavarapu, et al.
Published: (2024-06-01)
by: Srinivas Medavarapu, et al.
Published: (2024-06-01)
Mycoplasma pneumoniae-associated transverse myelitis presenting as asymmetric flaccid paralysis
by: Shafee Salloum, et al.
Published: (2019-09-01)
by: Shafee Salloum, et al.
Published: (2019-09-01)
Transverse myelitis as a presentation of systemic lupus erythematosus
by: A Batra, et al.
Published: (2011-01-01)
by: A Batra, et al.
Published: (2011-01-01)
Transverse myelitis caused by varicella zoster: case reports
by: Sema Yýlmaz, et al.
by: Sema Yýlmaz, et al.
Transverse myelitis in myelin oligodendrocyte glycoprotein antibody-associated disease
by: Gina Perez-Giraldo, et al.
Published: (2023-07-01)
by: Gina Perez-Giraldo, et al.
Published: (2023-07-01)
Longitudinally extensive transverse myelitis after Covid-19 vaccination: case report and review of literature
by: Seyed Farzad Maroufi, et al.
Published: (2022-01-01)
by: Seyed Farzad Maroufi, et al.
Published: (2022-01-01)
COVID-19 Vaccine—A Potential Trigger for MOGAD Transverse Myelitis in a Teenager—A Case Report and a Review of the Literature
by: Cristina Oana Mărginean, et al.
Published: (2022-05-01)
by: Cristina Oana Mărginean, et al.
Published: (2022-05-01)
Similar Items
-
Temporal association between the isolation of Sabin-related poliovirus vaccine strains and the Guillain-Barré syndrome
by: F. Friedrich, et al.
Published: (1996-02-01) -
A phase 2 study of a combined diphtheria-tetanus-acellular pertussis vaccine with a Sabin-derived inactivated poliovirus vaccine in children
by: Takashi Nakano, et al.
Published: (2018-12-01) -
Potency of the Sabin inactivated poliovirus vaccine (sIPV) after exposure to freezing temperatures in cold chains
by: Wei Cai, et al.
Published: (2020-08-01) -
Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine
by: Chiemi Hotta, et al.
Published: (2019-05-01) -
Effect of maternal antibody on the infant immune response to inactivated poliovirus vaccines made from Sabin strains
by: Rong Tang, et al.
Published: (2019-05-01)
